O'Donnell KC

NYU Grossman School of Medicine, New York, NY, USA.

8 papers · ORCID

ArticlePsychedelics

A Multi-Site Evaluation of a Psychedelic Medicine Curriculum for Psychiatry Trainees.

Yaden ME, O'Donnell KC, Roberts DE +10

Europe PMC2026
ArticlePsilocybin

Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research.

O'Donnell KC, Grigsby J, Grob CS

Europe PMC2025
ArticlePsilocybin

Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial.

Pagni BA, Zeifman RJ, Mennenga SE +6

Europe PMC2025
ArticleMDMA

The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD.

O'Donnell KC, Okano L, Alpert M +6

Europe PMC2024
ArticlePsilocybin

Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.

O'Donnell KC, Anderson BT, Barrett FS +9

Europe PMC2024
ArticlePsychedelics

What Is in a Name? The Many Meanings of "Psychedelic".

O'Donnell KC, Roberts DE, Ching THW +8

Europe PMC2023
ArticlePsilocybin

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.

Raison CL, Sanacora G, Woolley J +31

Europe PMC2023
ArticlePsilocybin

Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.

O'Donnell KC, Mennenga SE, Owens LT +6

Europe PMC2022